#regeneron — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #regeneron, aggregated by home.social.
-
https://www.europesays.com/dk/146724/ GLP-1 Demand Is Soaring. 2 Stocks That Could Benefit From This (Hint: Not Eli Lilly or Novo Nordisk) #Amgen #EliLilly #GrowthDriver #medicine #NovoNordisk #Regeneron #TheMotleyFool
-
https://www.europesays.com/dk/146232/ GLP-1 Demand Is Soaring. 2 Stocks That Could Benefit From This (Hint: Not Eli Lilly or Novo Nordisk) #Amgen #EliLilly #GrowthDriver #medicine #NovoNordisk #Regeneron #TheMotleyFool
-
Regeneron: Dupixent Sales Reach $6 Billion As Sanofi Repayment Unlocks Profit And Cash Flow Inflection
Regeneron reported strong second-quarter 2026 growth as global Dupixent sales reached approximately $6 billion and the biotechnology company…
#France #FR #Europe #EU #Sanofi #Regeneron
https://www.europesays.com/france/60575/ -
Regeneron Limerick has a job available that I could probably do and pays better than I'm currently making, but wow the reviews on Indeed are dire.
Has anybody worked there recently? What's it actually like? DMs are OK.
-
Regeneron Limerick has a job available that I could probably do and pays better than I'm currently making, but wow the reviews on Indeed are dire.
Has anybody worked there recently? What's it actually like? DMs are OK.
-
Regeneron Limerick has a job available that I could probably do and pays better than I'm currently making, but wow the reviews on Indeed are dire.
Has anybody worked there recently? What's it actually like? DMs are OK.
-
Regeneron Limerick has a job available that I could probably do and pays better than I'm currently making, but wow the reviews on Indeed are dire.
Has anybody worked there recently? What's it actually like? DMs are OK.
-
Regeneron Limerick has a job available that I could probably do and pays better than I'm currently making, but wow the reviews on Indeed are dire.
Has anybody worked there recently? What's it actually like? DMs are OK.
-
Can Sanofi Rely on Dupixent to Drive Long-Term Revenue Growth?
Sanofi’s SNY Dupixent, which it co-develops with Regeneron REGN, is its key top-line driver. The drug has transformed the treatment…
#France #FR #Europe #EU #Sanofi #approvedindications #atopicdermatitis #chronicrhinosinusitis #chronicspontaneousurticaria #Dupixent #inflammatorydiseases #Regeneron #severeasthma #ZacksInvestmentResearch
https://www.europesays.com/france/40120/ -
ATS 2026: Mixed results for Sanofi/Regeneron’s itepekimab cloud COPD prospects
On 16 May, during the 2026 American Thoracic Society (ATS) International Conference, Sanofi and Regeneron presented new safety…
#France #FR #Europe #EU #Sanofi #AmericanThoracicSociety #ATS #COPD #exacerbation #exacerbations #InternationalConference #PhaseIIIclinicaltrials #Regeneron #severechronicobstructivepulmonarydisease #smoking
https://www.europesays.com/france/20308/ -
Bayer to Acquire Perfuse for Up to $2.45B, Seeing Ophthalmology Opportunity
Laboratory assistant carries out a quality control in a Bayer laboratory. [Bayer] Bayer …
#Germany #DE #Europe #EU #Europa #Bayer #andtherapeutics #bayerpharmaceuticals #diabeticretinopathy #diagnosis #eylea #geneticengineeringandbiotechnology #glaucoma #industrynews #medicine #News #ophthalmicdiseases #regeneron #smallmolecules #systemicconditions #topics #translationalmedicine
https://www.europesays.com/germany/19218/ -
Toddler Captures Oval Office Spotlight Amid Policy Discussions
A 2-year-old boy's hearing was restored by a Regeneron drug, overshadowing talks on drug costs in the Oval Office on April 23, 2026.
#HearingRestoration, #DrugPricing, #OvalOffice, #Regeneron, #TravisSmith
https://newsletter.tf/toddler-hearing-restored-drug-price-talks/
-
A young child's personal medical success story became the main news, even as the government discussed lowering drug prices.
#HearingRestoration, #DrugPricing, #OvalOffice, #Regeneron, #TravisSmith
https://newsletter.tf/toddler-hearing-restored-drug-price-talks/ -
The Arithmetic of Absurdity: RFK Jr. Doubles Down on Trump’s Impossible Drug-Pricing Math
Math vs. Myth- by Winston Wendell Blue Press Journal - When it comes to economics, it feels like the current administration treats the laws of mathematics as more of a suggestion than a rule. On Thursday, Health and Human Services Secretary Robert F. Kennedy Jr. tried to patch up President Trump’s wild claims about prescription drug pricing, but ended up digging himself into an even deeper hole with his own calculations. Here’s where it gets weird: President Trump has a habit of […] -
The Arithmetic of Absurdity: RFK Jr. Doubles Down on Trump’s Impossible Drug-Pricing Math
Math vs. Myth- by Winston Wendell Blue Press Journal - When it comes to economics, it feels like the current administration treats the laws of mathematics as more of a suggestion than a rule. On Thursday, Health and Human Services Secretary Robert F. Kennedy Jr. tried to patch up President Trump’s wild claims about prescription drug pricing, but ended up digging himself into an even deeper hole with his own calculations. Here’s where it gets weird: President Trump has a habit of […] -
White House to announce drug pricing deal with Regeneron, source says
WASHINGTON, April 23 (Reuters) – The White House will announce a drug pricing deal with Regeneron Pharmaceuticals on…
#NewsBeep #News #Medication #AU #Australia #Health #PharmaceuticalCompanies #Regeneron #whitehouse
https://www.newsbeep.com/au/626470/ -
White House to announce drug pricing deal with Regeneron, source says
WASHINGTON, April 23 (Reuters) – The White House will announce a drug pricing deal with Regeneron Pharmaceuticals on…
#NewsBeep #News #Medication #AU #Australia #Health #PharmaceuticalCompanies #Regeneron #whitehouse
https://www.newsbeep.com/au/626470/ -
https://www.europesays.com/uk/913866/ White House to announce drug pricing deal with Regeneron, source says #Health #Medication #PharmaceuticalCompanies #Regeneron #UK #UnitedKingdom #WhiteHouse
-
https://www.europesays.com/ch/27589/ 2 Underrated Weight Loss Stocks to Buy Now #regeneron #Roche #StrongContender #WeightLoss
-
https://www.europesays.com/es/416836/ Respira impulsa un modelo coordinado para mejorar la atención del cáncer de pulmón no microcítico #C1 #Cáncer2026 #CancerDePulmón #ES #España #Health #Investigación #Regeneron #Salud #Spain
-
https://www.europesays.com/uk/593972/ SNY & REGN’s Dupixent Gets EU Nod for Chronic Spontaneous Urticaria #Antihistamines #ChronicRhinosinusitis #ChronicSpontaneousUrticaria #Dupixent #EuropeanCommission #EuropeanUnion #Health #InflammatoryDiseases #Medication #Regeneron #Sanofi #SevereAsthma #UK #UnitedKingdom #ZacksInvestmentResearch
-
https://www.europesays.com/ie/200303/ SNY & REGN’s Dupixent Gets EU Nod for Chronic Spontaneous Urticaria #Antihistamines #ChronicRhinosinusitis #ChronicSpontaneousUrticaria #Dupixent #Éire #EuropeanCommission #EuropeanUnion #Health #IE #InflammatoryDiseases #Ireland #Medication #Regeneron #Sanofi #SevereAsthma #ZacksInvestmentResearch
-
SNY & REGN’s Dupixent Gets EU Nod for Chronic Spontaneous Urticaria
Sanofi SNY and partner Regeneron REGN announced that the European Commission has approved Dupixent (dupilumab) for the …
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #antihistamines #chronicrhinosinusitis #chronicspontaneousurticaria #Dupixent #EuropeanCommission #EuropeanUnion #Health #inflammatorydiseases #Regeneron #Sanofi #severeasthma #ZacksInvestmentResearch
https://www.newsbeep.com/us/313749/ -
SNY & REGN’s Dupixent Gets EU Nod for Chronic Spontaneous Urticaria
Sanofi SNY and partner Regeneron REGN announced that the European Commission has approved Dupixent (dupilumab) for the …
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #antihistamines #chronicrhinosinusitis #chronicspontaneousurticaria #Dupixent #EuropeanCommission #EuropeanUnion #Health #inflammatorydiseases #Regeneron #Sanofi #severeasthma #ZacksInvestmentResearch
https://www.newsbeep.com/us/313749/ -
https://www.europesays.com/es/243276/ Profesionales sanitarios y pacientes de EPOC piden actualizar la Estrategia Nacional sobre la enfermedad | Líder en Información Social #Apepoc #COnEPOC #EPOC #EPOCEspaña #ES #España #Fenaer #Health #HipódromoDeLaZarzuela #Regeneron #Salud #Sanofi #Sociedad #Spain
-
Next medicine deal after Pfizer? Analysts, shares point to AstraZeneca, Eli Lilly
By Bhanvi Satija and Maggie Fick LONDON (Reuters) -Wall Street is looking to U.S. drugmaker Eli Lilly and…
#NewsBeep #News #Healthcare #AstraZeneca #AU #Australia #donaldtrump #EliLilly #GarethPowell #Health #Pfizer #Regeneron
https://www.newsbeep.com/au/211734/ -
18-Year-Old Proves Voter ID Laws Cut Turnout, Wins Science Award
18-year-old Rivka Lipkovitz used statistical modeling to show that states adopting strict voter ID laws saw a 2.4%…
#UnitedStates #US #USA #america #IDLaws #Regeneron #research #science #technology #Turnout #unitedstatesofamerica #voter
https://www.europesays.com/2416822/ -
DATE: May 23, 2025 at 05:00PM
SOURCE: HEALTHCARE INFO SECURITYDirect article link at end of text block below.
#ISMG Editors' Panel: #CrowdStrike Legal Storm Signals Bigger Risks; #Privacy Concerns in Planned #23andMe Purchase by #Regeneron https://t.co/wggRXU0iI8
Here are any URLs found in the article text:
Articles can be found by scrolling down the page at https://www.healthcareinfosecurity.com/ under the title "Latest"
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Healthcare security & privacy posts not related to IT or infosec are at @HIPAABot . Even so, they mix in some infosec with the legal & regulatory information.
-------------------------------------------------
#security #healthcare #doctors #itsecurity #hacking #doxxing #psychotherapy #securitynews #psychotherapist #mentalhealth #psychiatry #hospital #socialwork #datasecurity #webbeacons #cookies #HIPAA #privacy #datanalytics #healthcaresecurity #healthitsecurity #patientrecords @infosec #telehealth #netneutrality #socialengineering
-
DATE: May 21, 2025 at 08:23AM
SOURCE: HEALTHCARE INFO SECURITYDirect article link at end of text block below.
What are the potential data #privacy worries about #biotech firm #Regeneron's plans to buy #genetic testing company #23andMe? https://t.co/7cr2sY6haO
Here are any URLs found in the article text:
Articles can be found by scrolling down the page at https://www.healthcareinfosecurity.com/ under the title "Latest"
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Healthcare security & privacy posts not related to IT or infosec are at @HIPAABot . Even so, they mix in some infosec with the legal & regulatory information.
-------------------------------------------------
#security #healthcare #doctors #itsecurity #hacking #doxxing #psychotherapy #securitynews #psychotherapist #mentalhealth #psychiatry #hospital #socialwork #datasecurity #webbeacons #cookies #HIPAA #privacy #datanalytics #healthcaresecurity #healthitsecurity #patientrecords @infosec #telehealth #netneutrality #socialengineering
-
#23andMe Sale Shows Your #Genetic Data Is Worth $17
23andMe sold genetic data of 15M people for $256M to a #pharmaceutical #Regeneron. 23andMe does not perform full genome sequences. It instead does #DNA #genotyping, which look at parts of #genome that vary from person to person.
Sale to Regeneron means #gene data collected by 23andMe will be used for development of new #drugs, which felt like the most likely and perhaps best-case scenario for the company’s bankruptcy.
https://www.404media.co/23andme-sale-shows-your-genetic-data-is-worth-17/ -
#23andMe Sale Shows Your #Genetic Data Is Worth $17
23andMe sold genetic data of 15M people for $256M to a #pharmaceutical #Regeneron. 23andMe does not perform full genome sequences. It instead does #DNA #genotyping, which look at parts of #genome that vary from person to person.
Sale to Regeneron means #gene data collected by 23andMe will be used for development of new #drugs, which felt like the most likely and perhaps best-case scenario for the company’s bankruptcy.
https://www.404media.co/23andme-sale-shows-your-genetic-data-is-worth-17/ -
#23andMe Sale Shows Your #Genetic Data Is Worth $17
23andMe sold genetic data of 15M people for $256M to a #pharmaceutical #Regeneron. 23andMe does not perform full genome sequences. It instead does #DNA #genotyping, which look at parts of #genome that vary from person to person.
Sale to Regeneron means #gene data collected by 23andMe will be used for development of new #drugs, which felt like the most likely and perhaps best-case scenario for the company’s bankruptcy.
https://www.404media.co/23andme-sale-shows-your-genetic-data-is-worth-17/ -
#23andMe Sale Shows Your #Genetic Data Is Worth $17
23andMe sold genetic data of 15M people for $256M to a #pharmaceutical #Regeneron. 23andMe does not perform full genome sequences. It instead does #DNA #genotyping, which look at parts of #genome that vary from person to person.
Sale to Regeneron means #gene data collected by 23andMe will be used for development of new #drugs, which felt like the most likely and perhaps best-case scenario for the company’s bankruptcy.
https://www.404media.co/23andme-sale-shows-your-genetic-data-is-worth-17/ -
#23andMe Sale Shows Your #Genetic Data Is Worth $17
23andMe sold genetic data of 15M people for $256M to a #pharmaceutical #Regeneron. 23andMe does not perform full genome sequences. It instead does #DNA #genotyping, which look at parts of #genome that vary from person to person.
Sale to Regeneron means #gene data collected by 23andMe will be used for development of new #drugs, which felt like the most likely and perhaps best-case scenario for the company’s bankruptcy.
https://www.404media.co/23andme-sale-shows-your-genetic-data-is-worth-17/ -
Regeneron Pledges Privacy Protection in $256M Bid for 23andMe – Source: www.darkreading.com https://ciso2ciso.com/regeneron-pledges-privacy-protection-in-256m-bid-for-23andme-source-www-darkreading-com/ #rssfeedpostgeneratorecho #DarkReadingSecurity #CyberSecurityNews #DARKReading #Regeneron
-
Regeneron Pledges Privacy Protection in $256M Bid for 23andMe – Source: www.darkreading.com https://ciso2ciso.com/regeneron-pledges-privacy-protection-in-256m-bid-for-23andme-source-www-darkreading-com/ #rssfeedpostgeneratorecho #DarkReadingSecurity #CyberSecurityNews #DARKReading #Regeneron
-
Regeneron Pledges Privacy Protection in $256M Bid for 23andMe – Source: www.darkreading.com https://ciso2ciso.com/regeneron-pledges-privacy-protection-in-256m-bid-for-23andme-source-www-darkreading-com/ #rssfeedpostgeneratorecho #DarkReadingSecurity #CyberSecurityNews #DARKReading #Regeneron
-
Regeneron Pledges Privacy Protection in $256M Bid for 23andMe – Source: www.darkreading.com https://ciso2ciso.com/regeneron-pledges-privacy-protection-in-256m-bid-for-23andme-source-www-darkreading-com/ #rssfeedpostgeneratorecho #DarkReadingSecurity #CyberSecurityNews #DARKReading #Regeneron
-
23andMe and its customers’ genetic data bought by a pharmaceutical org https://www.malwarebytes.com/blog/news/2025/05/23andme-and-its-customers-genetic-data-bought-by-a-pharmaceutical-org #geneticdata #Regeneron #Privacy #23andMe #News
-
23andMe and its customers’ genetic data bought by a pharmaceutical org https://www.malwarebytes.com/blog/news/2025/05/23andme-and-its-customers-genetic-data-bought-by-a-pharmaceutical-org #geneticdata #Regeneron #Privacy #23andMe #News
-
23andMe and its customers’ genetic data bought by a pharmaceutical org https://www.malwarebytes.com/blog/news/2025/05/23andme-and-its-customers-genetic-data-bought-by-a-pharmaceutical-org #geneticdata #Regeneron #Privacy #23andMe #News
-
23andMe and its customers’ genetic data bought by a pharmaceutical org https://www.malwarebytes.com/blog/news/2025/05/23andme-and-its-customers-genetic-data-bought-by-a-pharmaceutical-org #geneticdata #Regeneron #Privacy #23andMe #News
-
After Bankruptcy, 23andMe Finds a Buyer in Regeneron—But What Happens to Your Data? https://thecyberexpress.com/regeneron-acquire-23andme/ #RegeneronPharmaceuticals #Regeneronacquire23andMe #Mergers&Aquisitions #TheCyberExpressNews #23andmeacquisition #TheCyberExpress #FirewallDaily #BusinessNews #CyberNews #Regeneron #23andme
-
After Bankruptcy, 23andMe Finds a Buyer in Regeneron—But What Happens to Your Data? https://thecyberexpress.com/regeneron-acquire-23andme/ #RegeneronPharmaceuticals #Regeneronacquire23andMe #Mergers&Aquisitions #TheCyberExpressNews #23andmeacquisition #TheCyberExpress #FirewallDaily #BusinessNews #CyberNews #Regeneron #23andme
-
After Bankruptcy, 23andMe Finds a Buyer in Regeneron—But What Happens to Your Data? https://thecyberexpress.com/regeneron-acquire-23andme/ #RegeneronPharmaceuticals #Regeneronacquire23andMe #Mergers&Aquisitions #TheCyberExpressNews #23andmeacquisition #TheCyberExpress #FirewallDaily #BusinessNews #CyberNews #Regeneron #23andme
-
🧬 Breaking: Regeneron acquires 23andMe's assets for $256M, including genome and research services—but not Lemonaid Health. Deal awaits court approval amid privacy safeguards.
-
🧬 Breaking: Regeneron acquires 23andMe's assets for $256M, including genome and research services—but not Lemonaid Health. Deal awaits court approval amid privacy safeguards.
-
#Biotech company #Regeneron to buy bankrupt #23andMe for $256M
Regeneron assured 23andMe's 15 million customers that their data—including #genetic and health information, #genealogy , and other sensitive personal information—would be safe and in good hands. Regeneron aims to use the large trove of genetic data to further its own work using genetics to develop medical advances—something 23andMe tried and failed to do.
#privacy #toshttps://arstechnica.com/science/2025/05/biotech-company-regeneron-to-buy-bankrupt-23andme-for-256m/
-
#Biotech company #Regeneron to buy bankrupt #23andMe for $256M
Regeneron assured 23andMe's 15 million customers that their data—including #genetic and health information, #genealogy , and other sensitive personal information—would be safe and in good hands. Regeneron aims to use the large trove of genetic data to further its own work using genetics to develop medical advances—something 23andMe tried and failed to do.
#privacy #toshttps://arstechnica.com/science/2025/05/biotech-company-regeneron-to-buy-bankrupt-23andme-for-256m/
-
#Biotech company #Regeneron to buy bankrupt #23andMe for $256M
Regeneron assured 23andMe's 15 million customers that their data—including #genetic and health information, #genealogy , and other sensitive personal information—would be safe and in good hands. Regeneron aims to use the large trove of genetic data to further its own work using genetics to develop medical advances—something 23andMe tried and failed to do.
#privacy #toshttps://arstechnica.com/science/2025/05/biotech-company-regeneron-to-buy-bankrupt-23andme-for-256m/
-
#Biotech company #Regeneron to buy bankrupt #23andMe for $256M
Regeneron assured 23andMe's 15 million customers that their data—including #genetic and health information, #genealogy , and other sensitive personal information—would be safe and in good hands. Regeneron aims to use the large trove of genetic data to further its own work using genetics to develop medical advances—something 23andMe tried and failed to do.
#privacy #toshttps://arstechnica.com/science/2025/05/biotech-company-regeneron-to-buy-bankrupt-23andme-for-256m/
-
#Biotech company #Regeneron to buy bankrupt #23andMe for $256M
Regeneron assured 23andMe's 15 million customers that their data—including #genetic and health information, #genealogy , and other sensitive personal information—would be safe and in good hands. Regeneron aims to use the large trove of genetic data to further its own work using genetics to develop medical advances—something 23andMe tried and failed to do.
#privacy #toshttps://arstechnica.com/science/2025/05/biotech-company-regeneron-to-buy-bankrupt-23andme-for-256m/
-
#23andMe Sale Shows Your #Genetic Data Is Worth $17
#Regeneron is a drug company that “intends to acquire 23andMe’s Personal #Genome Service (PGS), Total Health and Research Services business lines, together with its #Biobank and associated assets, for $256 million and for 23andMe to continue all consumer genome services uninterrupted,”
#privacy #dna #geneticshttps://www.404media.co/23andme-sale-shows-your-genetic-data-is-worth-17/
-
#23andMe Sale Shows Your #Genetic Data Is Worth $17
#Regeneron is a drug company that “intends to acquire 23andMe’s Personal #Genome Service (PGS), Total Health and Research Services business lines, together with its #Biobank and associated assets, for $256 million and for 23andMe to continue all consumer genome services uninterrupted,”
#privacy #dna #geneticshttps://www.404media.co/23andme-sale-shows-your-genetic-data-is-worth-17/
-
#23andMe Sale Shows Your #Genetic Data Is Worth $17
#Regeneron is a drug company that “intends to acquire 23andMe’s Personal #Genome Service (PGS), Total Health and Research Services business lines, together with its #Biobank and associated assets, for $256 million and for 23andMe to continue all consumer genome services uninterrupted,”
#privacy #dna #geneticshttps://www.404media.co/23andme-sale-shows-your-genetic-data-is-worth-17/
-
#23andMe Sale Shows Your #Genetic Data Is Worth $17
#Regeneron is a drug company that “intends to acquire 23andMe’s Personal #Genome Service (PGS), Total Health and Research Services business lines, together with its #Biobank and associated assets, for $256 million and for 23andMe to continue all consumer genome services uninterrupted,”
#privacy #dna #geneticshttps://www.404media.co/23andme-sale-shows-your-genetic-data-is-worth-17/
-
#23andMe Sale Shows Your #Genetic Data Is Worth $17
#Regeneron is a drug company that “intends to acquire 23andMe’s Personal #Genome Service (PGS), Total Health and Research Services business lines, together with its #Biobank and associated assets, for $256 million and for 23andMe to continue all consumer genome services uninterrupted,”
#privacy #dna #geneticshttps://www.404media.co/23andme-sale-shows-your-genetic-data-is-worth-17/
-
🚀 Brace yourselves, folks! #23andMe just hit the "sell" button faster than you can say "privacy concerns," offloading their gene-testing biz to the DNA wizards at #Regeneron. 🤖 Meanwhile, #Bloomberg is busy breaking news and breaking our patience with their endless #CAPTCHA tests. 🧬
https://www.bloomberg.com/news/articles/2025-05-19/23andme-sells-gene-testing-business-to-dna-drug-maker-regeneron #geneTesting #privacyConcerns #HackerNews #ngated -
🚀 Brace yourselves, folks! #23andMe just hit the "sell" button faster than you can say "privacy concerns," offloading their gene-testing biz to the DNA wizards at #Regeneron. 🤖 Meanwhile, #Bloomberg is busy breaking news and breaking our patience with their endless #CAPTCHA tests. 🧬
https://www.bloomberg.com/news/articles/2025-05-19/23andme-sells-gene-testing-business-to-dna-drug-maker-regeneron #geneTesting #privacyConcerns #HackerNews #ngated -
🚀 Brace yourselves, folks! #23andMe just hit the "sell" button faster than you can say "privacy concerns," offloading their gene-testing biz to the DNA wizards at #Regeneron. 🤖 Meanwhile, #Bloomberg is busy breaking news and breaking our patience with their endless #CAPTCHA tests. 🧬
https://www.bloomberg.com/news/articles/2025-05-19/23andme-sells-gene-testing-business-to-dna-drug-maker-regeneron #geneTesting #privacyConcerns #HackerNews #ngated